K. M. Pfarr and A. M. Hoerauf Pages 203 - 210 ( 8 )
Wolbachia endosymbionts of filariae are targets for the development of new antifilarial chemotherapy. Doxycycline to deplete Wolbachia from the worm has demonstrated the feasibility of this strategy and has provided a new chemotherapeutic tool. Recent research shows that depleting Wolbachia will also lessen pathology, and lessen adverse reactions to traditional antifilarial drugs.
Lymphatic filariasis, onchocerciasis, Wolbachia, tetracycline, doxycycline
Institute for MedicalMicrobiology, Immunology and Parasitology, University Clinic Bonn,Sigmund-Freud-Str. 25, D-53105 Bonn, Germany.